alzheon.comHealthcareFounded: 2013Funding to Date: $90.97MM
Alzheon is a biotechnology company focusued on developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.
For more details on financing and valuation for Alzheon, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Alzheon.
To read this article and more news on Alzheon, register or login.
